Phase-by-phase progression
See which compounds are moving through Phase I, II and III, which are stalling, and which are approaching regulatory decisions.
Every psilocybin, MDMA, ketamine and DMT trial — from Phase I to approval. Filter by phase, status, indication and sponsor to see where the field is really moving.
Blossom tracks every psychedelic clinical trial globally — recruitment status, protocol changes, interim results and final read-outs — synthesised daily from ClinicalTrials.gov, the EU CTR and beyond.
See which compounds are moving through Phase I, II and III, which are stalling, and which are approaching regulatory decisions.
Every trial linked to the sponsor running it, the sites recruiting, and the compounds being tested. Map the competitive landscape in minutes.
Filter for trials actively enrolling by indication and location — so patients, referrers and researchers find open studies fast.
Analysis
View a high-level snapshot of psychedelic research across topics, including total trials, participants, papers, pipeline distribution, and citation network patterns.